Metastatic tumors of the orbit: clinical and instrumental diagnosis

Purpose: to assess the clinical course of metastatic orbital tumors (MOT) and the results of instrumental examination of patients. Material and methods. 50 MOT patients aged 5–84 years (ave. 56.9 ± 14.3), including 41 women (82 %) and 9 men (18 %), were examined for the clinical signs, the laterality of the lesion, the size and shape of the tumor, the presence of oncology in the clinical history and its duration. All patients underwent ultrasound examination with color Doppler imaging (CDI), plus computer tomography (CT) or magnetic resonance imaging (MRI) of the orbits. In all cases, the diagnosis of MOT was confirmed morphologically. Results. 32 (64 %) patients had an oncology history, which lasted from 9 months to 23 years (median 5 years). The most frequently observed metastases were those of breast cancer (27 cases, 54 %), while other types occurred much less frequently: metastases of kidney cancer (4 cases) and stomach (3 cases), cancers of the reproductive systems (2 cases), melanoma (3 cases), thyroid cancer (1 case), and sarcomas (4 cases). The primary focus could not be detected in 3 patients (6 %). OD/OS orbit damages were observed in 23 patients (46 %)/ 21 patients (42 %), while 6 patients (12 %) had bilateral damages. Clinical symptoms included exophthalmos (35 cases, 70 %), enophthalmos (6 cases, 12 %), eye movement impairment (35 cases, 70 %), ptosis (35 cases, 70 %), eyelid edema (24 cases, 68 %), pain in the orbit (7 cases, 14 %), chemosis (12 cases, 24 %), difficulty in eye repositioning (32 cases, 64 %). Decreased visual acuity was noted in 13 cases (26 %). CT symptoms included infiltrative nature of the lesion (43 patients, 86 %), and solid tumors with clear and even contours (7 patients, 14 %). Bone wall changes were detected in 7 patients (14 %). Ultrasound data revealed a heterogeneous structure and an increased acoustic density of MOT. CDI detected own vessels in the projection of the tumor (15 patients). Conclusion. Orbital metastases present a multidisciplinary problem, which requires mandatory monitoring by physicians of various specialties, as only 36% of patients have no oncology in their clinical histories. Specific history features, the patient’s complaints, typical clinical symptoms, CT (MRI) and ultrasound data should alert the ophthalmologist about a possible MOT. A mandatory examination of patients with malignant neoplasms by an ophthalmologist is necessary to exclude ocular metastases.

1. Shields CL, Shields JA, Gross N, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997 Aug; 104 (8): 1265–76. doi: 10.1016/s0161-6420(97)30148-1

2. Grishina E.E. Metastic lesions of the eye. Russkij medicinskij zhurnal. Klinicheskaja oftal'mologija. 2001; 2 (1): 15–8 (In Russ.).

3. Allen RC. Orbital metastases: when to suspect? When to biopsy? Middle East Afr J Ophthalmol. 2018; 25 (2): 60–4. doi: 10.4103/meajo.MEAJO_93_18

4. Bonavolonta G, Strianese D, Grassi P, et al. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic Plast Reconstr Surg. 2013 Mar-Apr; 29 (2): 79–86. doi: 10.1097/IOP.0b013e31827a7622

5. Civit T, Colnat-Coulbois S, Freppel S. Métastases orbitaires [Orbital metastasis]. Neurochirurgie. 2010 Apr-Jun; 56 (2–3):148-51. (French). doi: 10.1016/j.neuchi.2010.02.008

6. Magliozzi P, Strianese D, Bonavolonta P, et al. Orbital metastases in Italy. Int J of Ophthalmol. 2015; 8 (5): 1018–23. doi:10.3980/j..2222-3959.2015.05.30

7. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery lecture, part I. Ophthalmology. 2004 May; 111 (5): 997–1008. doi: 10.1016/j.ophtha.2003.01.002

8. Valenzuela AA, Archibald CW, Fleming B, et al. Orbital metastasis: clinical features, management and outcome. Orbit. 2009; 28 (2–3): 153–9. doi: 10.1080/01676830902897470

9. Wladis EJ, Lee KW, Nazeer T. Metastases of systemic malignancies to the orbit: a major review. Orbit. 2021 Apr; 40 (2): 93–7. doi: 10.1080/01676830.2020.1759110

10. Brovkina A.F., Grishina E.E. Features of the clinical picture of lymphosarcoma and metastatic tumor of the orbit of another origin. Vestnik oftal'mologii. 1999; 5: 22–3 (In Russ.).

11. Chong VF. The orbits in cancer imaging. Cancer Imaging. 2006 Oct 31; 6 (Spec No A): S27–31. doi: 10.1102/1470-7330.2006.9003

12. Wang Y, Yang XJ, Li YY, Hei Y, Xiao LH. Diagnosis and management of orbital metastatic tumors. Zhonghua Yan Ke Za Zhi. 2008 Aug; 44 (8): 687–90. Chinese. PMID: 19115629

13. Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol. 2006 Apr; 34 (3): 239–44. doi: 10.1111/j.1442-9071.2006.01192.x

14. Kaprin A.D., Starinsky V.V., Shakhzadova A.O., eds. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Moscow: P.A. Gertsen MNIOI — filial FGBU “NMIC radiologii” Minzdrava Rossii. 2022 (In Russ.).

15. Grishina E.E. Metastases of solid tumors to the orbit. Difficulties in diagnosis (analysis of clinical cases). Almanac of Clinical Medicine 2015, Оctober; 41: 103–9. doi: 10.18786/2072-0505-2015-41-103-109

16. Shields JA, Shields CL, Brotman HK, et al. Cancer metastatic to the orbit. The 2000 Robert M. Curts lecture. Ophthalmic Plastic and Reconstructive Surgery. 2001; 17 (5): 346–54. doi: 10.1097/00002341-200109000-00009

17. Henderson JW, Campbell RJ, Farrow GM, et al. Metastatic carcinomas. In: Orbital tumors. 3rd ed. New York: Raven Press, 1994: 361–76.

18. Char DH, Miller T, Kroll S. Orbital metastasis: diagnosis and course. Br J Ophthalmol. 1997 May; 81 (5): 386–90. doi: 10.1136/bjo.81.5.3860

19. Fahmy P, Heegaard S, Jensen OA, Pause JU. Metastases in the ophthalmic region in Denmark 1969-98. A histological study. Acta Ophthalmol Scand. 2003 Feb; 81 (1): 47–50. doi: 10.1034/j.1600-0420.2003.00018.x

20. Eldesouky MA, Ekbakary MA. Clinical and imaging characteristics of orbital metastatic lesions in Egyptian patients. Clin Ophthalmol. 2015 Sep 10; 9: 1683–7. doi: 10.2147/OPTH.S87788

21. Yan J, Gao S. Metastatic orbital tumors in southern China during an 18-year period. Graefes Arch Clin Exp Ophthalmol. 2011 Sep; 249 (9): 1387–93. doi: 10.1007/s00417-011-1660-6

22. Tijl J, Koornneef L, Eijpe A, et al. Metastatic tumors to the orbit--management and prognosis. Graefes Arch Clin Exp Ophthalmol. 1992; 230 (6): 527–30. doi: 10.1007/BF00181773

23. Ng E, Ilsen PF. Orbital metastases. Optometry. 2010 Dec; 81 (12): 647–57. doi: 10.1016/j.optm.2010.07.026

24. Sklar BA, Gervasio KA, Karmazin K, Wu AY. Orbital metastasis from urothelial carcinoma: A Comprehensive literature review. Ophthalmic Plast Reconstr Surg. 2019 May/Jun; 35 (3): 213-17. doi: 10.1097/IOP.0000000000001256

25. Günalp I, Gündüz K. Metastatic orbital tumors. Jpn J Ophthalmol. 1995; 39 (1): 65–70. PMID: 7643486.

26. Goldberg RA, Rootman J. Clinical characteristics of metastatic orbital tumors. Ophthalmology. 1990 May; 97 (5): 620–4. doi: 10.1016/s0161-6420(90)32534-4

27. Kamieniarz L, Armeni E, O’Mahony LF, et al. Orbital metastasis from neuroendocrine neoplasms: clinical implications and outcomes. Endocrine. 2020; 67: 485-93. doi:10.1007/s12020/-019-02130-5

28. Ahmad SM, Esmaeli B. Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol. 2007; 18: 405–13. doi:10.1097/ICU.0b013e3282c5077c

29. Montejano-Milner R, López-Gaona A, Fernández-Pérez P, et al. Orbital metastasis: clinical presentation and survival in a series of 11 cases. Arch Soc Esp Oftalmol (Engl Ed). 2022 Feb; 97 (2): 81–8. doi: 10.1016/j.oftale.2020.07.014

30. Nickelsen MN, Holstein S, Hansen AB, Pause JU, Heegaard S. Breast carcinoma metastasis to the lacrimal gland: Two case reports. Oncol Lett. 2015 Aug; 10 (2): 1031–5. doi: 10.3892/ol.2015.3282

31. Iwanami M, Odaka M, Nakamura T, Hirata K. Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer. Brain Nerve. 2009 Sep; 61 (9): 1083–7. Japanese. PMID: 19803409.

32. Shields CL, Stopyra GA, Marr BP, Moster ML, Shields JA. Enophthalmos as initial manifestation of occult, mammogram-negative carcinoma of the breast. Ophthalmic Surg Lasers Imaging. 2004 Jan-Feb; 35 (1): 56–7. PMID: 14750765.

33. Cline RA, Rootman J. Enophthalmos: a clinical review. Ophthalmology. 1984 Mar; 91 (3): 229–37. doi: 10.1016/s0161-6420(84)34299-3

34. Pristupa V.V., Korolkova N.K., Kozhar V.L., Katulskaya T.V. Unilateral progressive enophthalmos caused by a tumor in the anterior orbit. Bulletin of Vitebsk State Medical University. 2020; 19 (5): 114–20 (In Russ.).

35. Novolodskaya O.I., Kogut I.D., Protsyk O.M. Clinical case of metastatic lesion of the external rectus muscle of the eye in breast cancer in ophthalmological practice. Modern technologies in ophthalmology. 2018; 2: 259–61 (In Russ.).

36. Arnold RW, Adams BA, Camoriano JK, Dyer JA. Acquired divergent strabismus: presumed metastatic gastric carcinoma to the medial rectus muscle. J Pediatr Ophthalmol Strabismus. 1989 Jan-Feb; 26 (1): 50–1. doi: 10.3928/0191-3913-19890101-13

37. Cherekaev V.A., Lasunin N.V., Stepanian M.A., et al. Breast carcinoma metastasis to the optic nerve: case report and review of literature. Burdenko's journal of neurosurgery. 2013; 77 (3): 42–8 (In Russ., In Engl.).

38. Laforga JB. Lacrimal gland metastasis from invasive lobular carcinoma (ER+, PR−, Her-2+) as the first manifestation of disseminated breast cancer. Breast J. 2020 Apr; 26 (4): 762–3. doi: 10.1111/tbj.1364

39. Lazebnik L.B., Suhareva G.V., Il'chenko L.Ju., Sivash E.S., Demchenko A.M. Bronchial carcinoid tumor with metastases to the lungs and orbit. Experimental and clinical gastroenterology. 2003; 5: 112–4 (In Russ.).

40. Andreeva L.D., Khoroshilova-Maslova I.P. Immunohistochemical studies of metastatic neoplasms of the eye and the orbit. Russian ophthalmological journal. 2012; 5 (1): 12–4 (In Russ.).

41. Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol. 1990 Jul-Aug; 35 (1): 1–24. doi: 10.1016/0039-6257(90)90045-w